FDA tells Purell to stop claiming it can prevent flu

Marketing campaign also claims product can prevent ebola spread


The Food and Drug Administration (FDA) told the maker of Purell to discontinue marketing campaigns that includes claims for avoiding flu and ebola, according to an article on The New York Times website.

The campaigns also claim the product can prevent spread of MRSA and norovirus.

The FDA told Gojo Industries that its claims that Purell could reduce the potential for infection or prevent illnesses violated the Federal Food, Drug and Cosmetic Act. 

The agency said it was reclassifying Purell as an unapproved drug, rather than an over-the-counter product.

Read the article.



February 10, 2020


Topic Area: Infection Control

Recent Posts

Building Envelope Design: Beyond Energy Efficiency

An integrated approach to envelope design can create more comfortable and energy-efficient hospitals.

Outpatient Surge Reshapes Long-Term Strategy for Medical Outpatient Buildings

Demographic tailwinds, policy uncertainty and shifting care models are pushing health systems to rethink how and where they invest in outpatient facilities.

Mercy Medical Center to Be Integrated into Baystate Health

Until the transition is complete and receives all regulatory approvals, Mercy Medical Center and Baystate Health will continue to operate independently.

Managing IAQ in Healthcare Facilities During Wildfires

Wildfires are becoming more prevalent across the country. Facilities must be prepared to handle their effects on air quality. 

Building Hospital Resilience in an Era of Extreme Weather

Expert Jennifer Mahan discusses the vulnerabilities healthcare facilities face during disasters and the infrastructure strategies that keep operations running.

 
 


FREE Newsletter Signup Form

News & Updates | Webcast Alerts
Building Technologies | & More!

 
 
 


All fields are required. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.